Storyboard

How the U.S. Botched Its Monkeypox Vaccine Rollout

Americans were told at the onset of the current outbreak that the United States was prepared with vaccine doses stockpiled away. But that wasn't the case: Millions of these doses were left to expire and a failure to ramp up vaccine production has resulted in a supply shortage. People are upset at the Biden administration's seemingly sluggish response. So what happened?

Avatar - The Science Desk
Curated by
The Science Desk
    • Health
    • Public Health
    • Science
    • Smallpox
    • Vaccination
How the U.S. Botched Its Monkeypox Vaccine Rollout
Continue to read
11 stories in this Storyboard

    The U.S. Thought It Was Prepared, But It Wasn't

    Smallpox vaccine for monkeypox: U.S. has 100 million doses stockpiled that could protect against monkeypox
    1.

    Smallpox vaccine for monkeypox: U.S. has 100 million doses stockpiled that could protect against monkeypox

    When Covid-19 struck, humanity faced an out-of-control outbreak without vaccines or therapies. If it were a knife fight, we brought a crayon. The level of preparedness for monkeypox couldn’t be more different. "We have vaccines squirreled away by our government," said Blossom Damania, a professor of …

    Read More About Monkeypox

Related articles

More stories from Health